parkinson glutathione oxidative ipsc crispr

parkinson glutathione oxidative ipsc crispr Decreases Parkinsonism‐Induced Ferroptosis and Stress Through the Inhibition of the TRPM2 Channel in Neuronal Cells - Güzel - 2025 - Pharmacology Research & Perspectives CRISPR/Cas9 assisted stem cell therapy

Name: parkinson glutathione oxidative ipsc crispr Decreases Parkinsonism‐Induced Ferroptosis and Stress Through the Inhibition of the TRPM2 Channel in Neuronal Cells - Güzel - 2025 - Pharmacology Research & Perspectives CRISPR/Cas9 assisted stem cell therapy
Brand: webdevsolutions.tech
SKU: 21171386816
Price: 23.22 USD
Availability: InStock
Rating: 4.0765 (16 reviews)

CRISPR Cas9 assisted stem cell therapy in Parkinson's disease Biomaterials Research Springer Nature Link Non invasive CRISPR Cas9 nanocapsules specifically edit synuclein for effective Parkinson's disease treatment ScienceDirect Frontiers Understanding Parkinson's disease: current trends and its multifaceted complications CRISPR Cas9 assisted stem cell therapy in Parkinson's disease Biomaterials Research

SKU: 21171386816 · From webdevsolutions.tech

4.1

USD23.22 USD67.22

Pay in 4 interest-free payments of $5.80 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 19 - Aug 24

Description

Defferriere, T., Klotz, D., Gonzalez-Rosillo, J

demonstrated that in CRC liver metastasis, ALDOB enhances tumor cell growth by facilitating fructose metabolism, allowing tumor cells to adapt their metabolic pathways to utilize available sugar sources in the liver's new microenvironment through the action of ALDOB